Systemic complications of the cosmetic use of skin-bleaching products

International Journal of Dermatology

Volumn 44, Issue SUPPL. 1, 2005, Pages 37-38

  Mahé, Antoine ^a,b,c   Ly, Fatimata ^a,b   Perret, Jean Luc ^a,b  

^a Institute for Social Hygiene   (Senegal)

^b HIA Legouest   (France)

^c NONE   (Gabon)

Author keywords

[No Author keywords available]

Indexed keywords

BLEACHING AGENT; CLOBETASOL PROPIONATE; CORTICOSTEROID; HYDROCORTISONE; HYDROQUINONE; MERCURIC CHLORIDE; MERCURY DERIVATIVE; SALICYLIC ACID DERIVATIVE;

ADRENAL INSUFFICIENCY; AFRICA; ARTICLE; BLEACHING; BODY BUILDING; CELLULITIS; CHEMICAL CARCINOGENESIS; CUSHING SYNDROME; DIABETES MELLITUS; ERYSIPELAS; ESTHETICS; FETOTOXICITY; HUMAN; HYDROCORTISONE RELEASE; HYPERTENSION; IATROGENIC DISEASE; MERCURIALISM; MUTAGENIC ACTIVITY; NEPHROTOXICITY; NEUROTOXICITY; NONHUMAN; RAT; RISK ASSESSMENT; RISK FACTOR; SYSTEMIC DISEASE;

AFRICAN CONTINENTAL ANCESTRY GROUP; COSMETICS; FEMALE; GLUCOCORTICOIDS; HUMANS; HYDROQUINONES; MERCURY COMPOUNDS; SENEGAL; SKIN PIGMENTATION;

EID: 27544450014     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2005.02810.x     Document Type: Article

References (13)

1. Mahé A, Blanc L, Halna JM, et al. Enquête épidémiologique sur l'utilisation cosmétique de produits dépigmentants par les femmes de Bamako (Mali). Ann Dermatol Venereol 1993; 120: 870-873.
2. Mahé A, Ly F, Aymard G, et al. Skin diseases associated with the cosmetic use of bleaching products in women from Dakar, Senegal. Br J Dermatol 2003; 148: 493-500.
3. Harada M, Nakachi S, Tasaka K, et al. Wide use of skin-lightening soap may cause mercury poisoning in Kenya. Sci Total Environ 2001; 269: 183-187.
4. Barr RD, Rees PH, Cordy P, et al. Nephrotic syndrome in adult Africans in Nairobi. Br Med J 1972; ii: 131-134.
5. Morbidity and Mortality Weekly Report. Mercury poisoning associated with beauty cream - Texas, New Mexico, and California, 1995-96. Arch Dermatol 1996; 132: 1533-1534.
6. Lauwerys R, Bonnier C, Evrard P, et al. Prenatal and early postnatal intoxication by inorganic mercury resulting from the maternal use of mercury containing soap. Hum Toxicol 1987; 6: 253-256.
7. DeCaprio AP. The toxicology of hydroquinone - relevance to occupational and environmental exposure. Crit Rev Toxicol 1999; 29: 283-330.
8. Thierno MT, Diop NG, Niang SO, et al. Dermohypodermite bactérienne et dépigmentation artificielle. A propos de 60 cas observés au Sénégal. Nouv Dermatol 2001; 20: 630-632.
9. Keane FM, Munn SE, Taylor NF, et al. Unregulated use of clobetasol propionate. Br J Dermatol 2001; 144: 1095-1096.
10. Perret JL, Sane M, Gning S, et al. Freinage hypothalamo-hypophyso-surrénalien lié à l'usage de cosmétiques dépigmentants au Sénégal. Bull Soc Pathol Exot 2001; 94: 249-252.
11. Sobngwy E, Lubin V, Ury P, et al. Adrenal insufficiency and diabetes mellitus secondary to the use of topical corticosteroids for cosmetic purpose. Ann Endocrinol (Paris) 2003; 64: 202-204.
12. Raynaud E, Cellier C, Perret JL. Dépigmentation cutanée à visée cosmétique. Enquête de prévalence et effets indésirables dans une population féminine sénégalaise. Ann Dermatol Venereol 2000; 128: 720-724.
13. Mahé A, Ly F, Gounongbé A. L'utilisation cosmétique de produits dépigmentants à Dakar (Sénégal): facteurs socio-économiques et motivations individuelles. Sci Sociales Santé 2004; 22: 5-33.